Find your next paid study

University of Wisconsin, MadisonNCT06654310

Actual pay is set by the research site.

Hormone Receptor Positive Breast Cancer

STRIDE: Evidence-Based Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy

The goal of this study is to demonstrate the efficacy of an evidence-based, small-group, telehealth intervention ('STRIDE') for improving patients' ability to …

Massachusetts General HospitalNCT07759947

Actual pay is set by the research site.

Phase 2

Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (Tocilizumab) for the Treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) J…

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

Nationwide Children's HospitalNCT05233397

~$75 – $2,000

Actual pay is set by the research site.

Breast CancerBreast Cancer Recurrent

Partial Breast Re-irradiation Using Ultra Hypofractionation: Phase 2 Multi-institutional Study (PRESERVE)

Breast-conserving surgery followed by re-irradiation with partial breast irradiation (rPBI) has recently been found to be a safe alternative to mastectomy for …

University Health Network, TorontoNCT05592938

Actual pay is set by the research site.

Randomized, Prospective Controlled Head-to-head Clinical Trial Comparing a Bioengineered Skin Substitute to a Biologically Active Human Skin Allograft for the Treatment of Venous Leg Ulcers.

Given the propensity for venous leg ulcers to become refractory, long standing lesions, incorporating active biologic grafts into the standard compression ther…

Venous Leg Ulcers

Solsys Medical LLCNCT02047084

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

A Phase 1b/2a, Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Activity of Small Mobile Stem Cells (SMS) Delivered Into the Lung as a Potential Organ Regeneration Therapy in Moderate to Severe Chronic Obstructive Pulmonary Disease (SORT-COPD Study II)

This study is a phase 1b/2a, open-label, non-randomized, observation of 125 adults, with moderate to severe chronic obstructive pulmonary disease, treated with…

Chronic Obstructive Lung Disease

Duchenne Muscular Dystrophy

~$150 – $4,200

Actual pay is set by the research site.

SMSbiotechNCT07871890

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy [SUpplemental Patient dMd assessMents Investigating ouTcomes (SUMMIT)]

The goal of this study is to collect additional information on the safety of long-term treatment with AGAMREE® and to explore long-term clinical impact of AGAM…

Catalyst Pharmaceuticals, Inc.NCT06564974

~$10 – $1,050

Actual pay is set by the research site.

Visual Field DefectStrokeHemianopia+5 more

Visual Plasticity Following Brain Lesions

The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-…

Georgetown UniversityNCT07105358

Actual pay is set by the research site.

Phase 1

Metformin and Muscle Recovery Following ACL Surgery

The purpose of this research study is to determine if Metformin taken after anterior cruciate ligament reconstruction (ACLR) surgery can decrease muscle fibros…

AtrophyInflammationWeakness, Muscle

University of UtahNCT07699367

~$150 – $3,000

Actual pay is set by the research site.

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

The primary objectives of this prospective mixed-method interview study are to use semi-structured interviews in parents of sickle cell disease (SCD) patients …

Sickle Cell Disease

St. Jude Children's Research HospitalNCT04416178

Actual pay is set by the research site.

Acute Myeloid LeukemiaB Acute Lymphoblastic LeukemiaB Lymphoblastic Lymphoma+1 more

Red Blood Cell Transfusion Threshold-Specific Bleeding, Quality of Life and Functional Outcomes in Acute Leukemia Patients With Thrombocytopenia: a Randomized Feasibility Study

This clinical trial evaluates the effects of hemoglobin threshold-specific packed red blood cell (PRBC) transfusions on quality of life and functional outcomes…

University of WashingtonNCT06710418

Actual pay is set by the research site.

Phase 1

Phase 1b Dose Escalation Trial of OMTX705, an Anti-Fibroblast Activation Protein Antibody-Drug Conjugate, in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast activation protein (FAP) antibody-drug conjugate (ADC), in combination with gemcitabine…

Pancreatic Adenocarcinoma Metastatic